Cerebral, Inc., a telehealth company, has agreed to settle Federal Trade Commission (FTC) charges over its failure to secure and protect sensitive consumer health data. The settlement includes a $7 million fine for disclosing consumers’ personal health information to third parties for advertising purposes and failing to uphold its cancellation policies. The FTC claimed that Cerebral violated privacy rights by revealing sensitive mental health conditions across the internet and in the mail. The proposed order will restrict Cerebral’s use and disclosure of sensitive consumer data and require the company to implement a comprehensive privacy and data security program. The order, which must be approved by a court, also mandates that Cerebral provide an easy way for consumers to cancel services.
Proposed FTC Order will Prohibit Telehealth Firm Cerebral from Using or Disclosing Sensitive Data for Advertising Purposes, and Require it to Pay $7 Million
More Issues
Wade’s Health Law Highlights for November 10, 2026
Texas secured a $45 million settlement with Gilead Sciences over manufacturer patient support programs it treated as illegal inducements under state law. The Texas…
Wade’s Health Law Highlights for November 3, 2026
HHS will not take enforcement action against 503A compounding pharmacies that make six peptides FDA removed from the compounding bulks list in 2023. The…
Wade’s Health Law Highlights for October 27, 2026
Gilead Sciences agreed to pay Texas $45 million to resolve claims that it offered kickbacks to providers that influenced Texas Medicaid prescriptions. The Texas…
